(43 days)
Stöckert S5 System
Not Found
No
The summary does not mention AI, ML, or any related concepts like image processing, training sets, or performance metrics typically associated with AI/ML devices. The description focuses on the hardware and software of a modular system for cardiopulmonary bypass.
Yes
The device is described as being used during cardiopulmonary bypass surgery, which is a medical procedure to support heart and lung function. This indicates a direct therapeutic application for patient treatment.
No
The Stöckert S5 System is described as being used during cardiopulmonary bypass surgery, indicating it is an interventional or therapeutic device, not a diagnostic one. Its components like pumps and controls further support this role rather than diagnosis.
No
The device description explicitly states it is a "modular system consisting of a console, various pumps, monitors, displays, controls, and user interfaces," indicating it includes significant hardware components. The performance studies also mention testing of both "hardware and software."
Based on the provided information, the Stöckert S5 System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use clearly states it's for use during cardiopulmonary bypass surgery. This is a surgical procedure performed on a patient, not a test performed on a sample taken from a patient.
- Device Description: The description details a system with pumps, monitors, displays, and controls used in a surgical setting. This aligns with a medical device used for patient support during surgery, not for analyzing biological samples.
- Lack of IVD Indicators: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), performing tests on these samples, or providing diagnostic information based on such analysis.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for the diagnosis, monitoring, or treatment of a disease or condition. The Stöckert S5 System's function is to support a patient's circulatory and respiratory systems during surgery.
N/A
Intended Use / Indications for Use
The Stöckert S5 System is intended to be used during cardiopulmonary bypass surgery lasting six (6) hours or less.
Product codes
DTQ
Device Description
The modified Stöckert S5 System, like the parent S5 System, is a modular system consisting of a console, various pumps, monitors, displays, controls, and user interfaces.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing of the modified Stöckert S5 System (hardware and software) has demonstrated that the System fulfills prospectively defined performance criteria and that the modified System meets user needs.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Stöckert S5 System
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.4220 Cardiopulmonary bypass heart-lung machine console.
(a)
Identification. A cardiopulmonary bypass heart-lung machine console is a device that consists of a control panel and the electrical power and control circuitry for a heart-lung machine. The console is designed to interface with the basic units used in a gas exchange system, including the pumps, oxygenator, and heat exchanger.(b)
Classification. Class II (performance standards).
0
SEP 2 8 2006
APPENDIX C
"
510(k) Summary
:
Sorin Group Deutschland GmbH August 15, 2006 Special 510(k): Device Modification - Stöckert S5 System
APPENDIX C
1
510(k) Summary Sorin Group Deutschland GmbH Stöckert S5 System (per 21 CFR 807.92)
1. SPONSOR
Sorin Group Deutschland GmbH Lindberghstrasse 25 80939 Munich Germany Contact Person: Helmut Höfl Telephone: 011 49 89 323 010
Date Prepared: August 15, 2006
2. DEVICE NAME
Proprietary Name: Stöckert S5 System Common/Usual Name: Heart lung machine Classification Name: Multiple
3. PREDICATE DEVICES
Stöckert S5 System
4. DEVICE DESCRIPTION
The modified Stöckert S5 System, like the parent S5 System, is a modular system consisting of a console, various pumps, monitors, displays, controls, and user interfaces.
5. INTENDED USE
The Stöckert S5 System is intended to be used during cardiopulmonary bypass surgery lasting six (6) hours or less.
2
6. TECHNOLOGICAL CHARACTERISTICS AND SUBSTANTIAL EQUIVALENCE
The modified Stöckert S5 System is an upgrade of the parent Stöckert S5 System. The modified Stöckert S5 System is substantially equivalent to the parent Stöckert S5 System based on intended use, indication for use, operational characteristics, and fundamental technological characteristics.
PERFORMANCE TESTING 7.
Testing of the modified Stöckert S5 System (hardware and software) has demonstrated that the System fulfills prospectively defined performance criteria and that the modified System meets user needs.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health and Human Services (HHS). The logo features the department's name in a circular arrangement around a stylized symbol. The symbol consists of four abstract shapes resembling a human figure or a bird in flight, with the shapes stacked vertically and slightly offset from each other.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 2 8 2006
Medical Device Consultants, Inc. c/o Ms. Rosina Robinson Principal Consultant, Regulatory Services 49 Plain Street North Attleboro, MA 02760
Re: K062396 Stöckert S5 System Regulation Number: 21 CFR 870.4220 Regulation Name: Cardiopulmonary Bypass Heart Lung Machine Console Regulatory Class: Class II (two) Product Code: DTQ Dated: September 18, 2006 Received: September 19, 2006
Dear Ms. Robinson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Ms. Rosina Robinson
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) promation notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Anna R. Vachner
Image /page/4/Picture/6 description: The image shows a black and white abstract drawing. The drawing appears to be a stylized signature or symbol. It features curved lines and sharp angles, creating a unique and somewhat complex design. The lines are thick and bold, making the symbol stand out against the white background.
A Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(k) Number (if known): K062396
Device Name: _________________________________________________________________________________________________________________________________________________________________
Indications for Use:
:
The Stöckert S5 System is intended to be used during cardiopulmonary bypass for procedures lasting six (6) hours or less.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
R. Vachner
(Division Sign-Off) Division of Cardiovascular Devices
510(k) Number_k 662396